-
Mashup Score: 0Kashyap Patel, MD, Sees Link Between COVID-19 and Cancer Progression, Calls for More Biomarker Testing - 1 year(s) ago
Recent papers highlight possible role of inflammation in connections between COVID-19, cancer markers.
Source: AJMCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Axi-Cel Improves Overall Survival vs Standard-of-Care Initial Treatment for R/R LBCL - 1 year(s) ago
A prespecified overall survival analysis of the phase 3 ZUMA-7 trial found that axicabtagene ciloleucel (axi-cel) led to better outcomes vs the historical standard of care for relapsed or refractory large B-cell lymphoma (R/R LBCL).
Source: AJMCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Axi-Cel Improves Overall Survival vs Standard-of-Care Initial Treatment for R/R LBCL @KitePharma #Yescarta https://t.co/VuGKfawnXJ via @AJMC
-
-
Mashup Score: 0COA to Celebrate 20 Years of Advocacy at Annual Conference - 1 year(s) ago
Topics to be addressed at the annual conference, which will bring more than 1900 attendees to Kissimmee, Florida, include the Enhancing Oncology Model, efforts to regulate pharmacy benefit managers (PBMs), and 340B reform.
Source: AJMCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
This week members of @oncologyCOA gather for their annual conference in Florida. Here's our preview. https://t.co/7O1fshrh3J
-
-
Mashup Score: 2Study of South African Males With Prostate Cancer Reveals Limits of Current Germline Testing - 1 year(s) ago
The findings, published in the Journal of the National Comprehensive Cancer Network, add to the evidence that the shift to precision medicine is built on data that have not included sufficient numbers of patients of color.
Source: AJMCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Study of South African Males With #Prostate Cancer Reveals Limits of Current Germline Testing @JNCCN @KashyappatelMd https://t.co/2hHEtNHDzI via @AJMC
-
-
Mashup Score: 0
A session at the ACCC 2023 Annual Meeting and Cancer Center Business Summit addressed the promise and potential drawbacks of multicancer early detection (MCED) testing for patients in the primary care setting.
Source: AJMCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Multicancer Early Detection May Change the Screening Game—If We Learn From the Past #AMBCSS @ACCCBuzz https://t.co/IrL3A8mPvc via @AJMC
-
-
Mashup Score: 0CRISPR Holds Promise in Cancer Treatment, but Challenges Remain - 1 year(s) ago
In the first keynote session at the ACCC 2023 Annual Meeting and Cancer Center Business Summit, the history of CRISPR genome editing and its potential in cancer and other settings took center stage.
Source: AJMCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
CRISPR Holds Promise in Cancer Treatment, but Challenges Remain #ACCC2023 https://t.co/r96EVXb2he via @AJMC
-
-
Mashup Score: 0Finding Quality in Cancer Care Beyond the Hospital Walls - 1 year(s) ago
Coverage from the January 18, 2023, Institute for Value-Based Medicine session with Regional Cancer Care Associates held in New Brunswick, New Jersey.
Source: AJMCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Finding Quality in Cancer Care Beyond the Hospital Walls https://t.co/r8HQjH1YzI via @AJMC @ThymeCares @UABNews #IVBM
-
-
Mashup Score: 0ASH Guideline Champions Detail Ways to Improve Quality and Outcomes, Trim Hospitalizations - 1 year(s) ago
Coverage from the 64th American Society of Hematology Annual Meeting and Exposition, held December 10-13, 2022, in New Orleans, Louisiana.
Source: AJMCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ICYMI: @ASH_hematology Guideline Champions Detail Ways to Improve #Quality and Outcomes, Trim Hospitalizations https://t.co/JajMzi3lMa via @AJMC
-
-
Mashup Score: 0FDA Gives Zanubrutinib Approval for First-line, R/R CLL/SLL - 1 year(s) ago
The broad approval, while expected, will likely signal a milestone in the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
Source: AJMCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
UPDATED w. comments from Dr Jennifer Brown @DanaFarber “There is no situation in which I would start a patient on ibrutinib anymore.”FDA Gives Zanubrutinib Approval for First-line, R/R CLL/SLL https://t.co/V2CTNFeowk via @AJMC
-
-
Mashup Score: 0ASH Guideline Champions Detail Ways to Improve Quality and Outcomes, Trim Hospitalizations - 1 year(s) ago
Coverage from the 64th American Society of Hematology Annual Meeting and Exposition, held December 10-13, 2022, in New Orleans, Louisiana.
Source: AJMCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ASH Guideline Champions Detail Ways to Improve Quality and Outcomes, Trim Hospitalizations @ASH_hematology @uabmedicine @UMRogelCancer https://t.co/JajMzi2NWC via @AJMC
-
Kashyap Patel, MD, Sees Link Between #COVID19 and Cancer Progression, Calls for More #biomarker Testing https://t.co/dvDoERcR2d via @AJMC